CA

Eric J Arts

This inventor holds 1 USPTO granted patent. Top assignee: Case Western Reserve University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric J Arts. Retrieved from https://idiyas.com/inventor/eric-j-arts-0aj24bwk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric J Arts: Innovator in HIV-1 Treatment

Introduction

Eric J Arts is a notable inventor based in California, recognized for his contributions to the field of HIV research. His innovative work focuses on developing treatments for latent HIV-1 infections, which is a significant area of study in the fight against HIV/AIDS.

Latest Patents

Eric J Arts holds a patent titled "Autologous and Allogenic HIV-1 Proteins for the Treatment of Latent HIV-1 Infection." This patent represents a crucial advancement in therapeutic strategies aimed at addressing the challenges posed by latent HIV-1.

Career Highlights

Eric is affiliated with Case Western Reserve University, where he continues to engage in groundbreaking research. His work has the potential to impact the lives of many individuals living with HIV, providing new avenues for treatment and management of the virus.

Collaborations

Eric collaborates with Jamie Mann, contributing to a dynamic research environment that fosters innovation and discovery in the field of HIV treatment.

Conclusion

Eric J Arts exemplifies the spirit of innovation in medical research, particularly in the realm of HIV treatment. His contributions are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…